In PD cases, there was an increase in the levels of mGluR5 in the membrane fraction of the caudo-putamen (Figure 2E, F), but levels in the frontal cortex and hippocampus were comparable to controls (Figure 2A–D). This evidence concerns the gene GRM5 and Parkinson disease.